XML 45 R33.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Stock-based compensation |
Schedule of compensation expense | Stock-based compensation cost from continuing operations by award type follows:
(in millions) |  | 2020 |  | 2019 |  | 2018
Stock option awards |  | $ | 10.4 |  |  | $ | 9.9 |  |  | $ | 10.4 |
Restricted stock awards |  | 8.6 |  |  | 6.9 |  |  | 7.2 |
Performance share awards |  | 7.4 |  |  | 5.5 |  |  | 6.9 |
Restricted stock units |  | 1.4 |  |  | 1.3 |  |  | 1.4 |
Stock appreciation rights |  | 2.4 |  |  | 7.1 |  |  | — |
Total stock-based compensation cost incurred |  | 30.2 |  |  | 30.7 |  |  | 25.9 |
Capitalized cost during the period |  | (3.5) |  |  | (9.0) |  |  | (1.1) |
Amortization of capitalized cost during the period |  | 1.2 |  |  | 6.7 |  |  | 0.6 |
Total stock-based compensation expense |  | $ | 27.9 |  |  | $ | 28.4 |  |  | $ | 25.4 |
Income tax benefit |  | $ | 8.8 |  |  | $ | 11.9 |  |  | $ | 9.8 |
Schedule of weighted-average assumptions for equity awards | The weighted average assumptions used in the determination of fair value for stock options follows:
(in millions, except per share amounts) |  | 2020 |  | 2019 |  | 2018 |  | 2018 One-time Grant
Expected dividend yield |  | 1.3 | % |  | 1.6 | % |  | 1.4 | % |  | 1.4 | %
Expected term (in years) |  | 4.8 |  | 4.9 |  | 5.5 |  | 3.9
Expected volatility |  | 21.9 | % |  | 21.3 | % |  | 23.1 | % |  | 20.7 | %
Risk-free interest rate |  | 1.4 | % |  | 2.5 | % |  | 2.6 | % |  | 2.6 | %
Weighted-average grant date fair value (per share) |  | $ | 29.29 |  |  | $ | 21.07 |  |  | $ | 23.71 |  |  | $ | 21.91 |
Fair value of options granted |  | $ | 11.6 |  |  | $ | 9.7 |  |  | $ | 9.1 |  |  | $ | 13.6 |
Schedule of stock option activity under the Company's stock option awards | A summary of stock options outstanding and activity follows:
|  | Number of Shares (in thousands) |  | Weighted-Average Exercise Price (per share) |  | Weighted-Average Contractual Term (in years) |  | Aggregate Intrinsic Value (in millions)
Outstanding as of December 31, 2019 |  | 1,825 |  |  | $ | 101.95 |  |  |  |  |
Options granted |  | 395 |  |  | 159.49 |  |  |  |  |
Options exercised |  | (229) |  |  | 95.49 |  |  |  |  |
Options forfeited / expired |  | (165) |  |  | 119.11 |  |  |  |  |
Outstanding as of December 31, 2020 |  | 1,826 |  |  | 114.03 |  |  | 7.0 |  | $ | 78.8 |
Vested and exercisable as of December 31, 2020 |  | 768 |  |  | 98.25 |  |  | 5.4 |  | $ | 44.5 |
Additional information related to stock option activity during the years ended December 31 follows:
(in millions) |  | 2020 |  | 2019 |  | 2018
Intrinsic value of options exercised |  | $ | 11.9 |  |  | $ | 25.4 |  |  | $ | 18.4 |
Fair value of options vested |  | $ | 7.9 |  |  | $ | 6.3 |  |  | $ | 10.2 |
Schedule of activity related to restricted stock | Information related to restricted stock during the years ended December 31 follows:
|  | 2020 |  | 2019 |  | 2018
Weighted-average grant date fair value (per share) |  | $ | 147.78 |  |  | $ | 112.70 |  |  | $ | 114.27 |
A summary of restricted stock outstanding and activity follows:
|  | Number of Shares (in thousands) |  | Weighted-Average Grant Date Fair Value (per share) |  | Weighted-Average Contractual Term (in years) |  | Aggregate Intrinsic Value (in millions)
Outstanding as of December 31, 2019 |  | 173 |  |  | $ | 109.62 |  |  |  |  |
Shares granted |  | 69 |  |  | 147.78 |  |  |  |  |
Shares vested |  | (66) |  |  | 114.39 |  |  |  |  |
Shares forfeited |  | (10) |  |  | 123.70 |  |  |  |  |
Outstanding as of December 31, 2020 |  | 166 |  |  | 122.88 |  |  | 0.8 |  | $ | 26.0 |
Additional information related to restricted stock award activity during the years ended December 31 follows:
(in millions) |  | 2020 |  | 2019 |  | 2018
Intrinsic value of restricted stock exercised |  | $ | 9.6 |  |  | $ | 5.6 |  |  | $ | 11.7 |
Fair value of restricted stock vested |  | $ | 7.5 |  |  | $ | 4.6 |  |  | $ | 9.8 |
Additional information related to restricted stock unit activity during the years ended December 31 follows:
(in thousands, except per share amounts) |  | 2020 |  | 2019 |  | 2018
Restricted stock units granted |  | 8 |  |  | 12 |  |  | 13 |
Weighted-average grant date fair value (per share)(1) |  | $ | 161.41 |  |  | $ | 110.79 |  |  | $ | 108.72 |
(1)Restricted stock units' fair value is based on the closing market price of the stock on the respective dates of the grants.
Schedule of activity related to performance shares | Information related to performance shares during the years ended December 31 follows:
|  | 2020 |  | 2019 |  | 2018
Weighted-average grant date fair value (per share) |  | $ | 222.50 |  |  | $ | 149.27 |  |  | $ | 140.20 |
A summary of performance shares outstanding and activity follows:
|  | Number of Shares (in thousands) |  | Weighted-Average Grant Date Fair Value (per share) |  | Weighted-Average Contractual Term (in years) |  | Aggregate Intrinsic Value (in millions)
Outstanding as of December 31, 2019 |  | 143 |  |  | $ | 143.94 |  |  |  |  |
Awards granted |  | 46 |  |  | 222.50 |  |  |  |  |
Awards vested |  | (80) |  |  | 141.79 |  |  |  |  |
Awards converted |  | 36 |  |  | 141.81 |  |  |  |  |
Awards forfeited |  | (9) |  |  | 167.03 |  |  |  |  |
Outstanding as of December 31, 2020 |  | 136 |  |  | 170.34 |  |  | 0.9 |  | $ | 21.2 |
Additional information related to performance share activity during the years ended December 31 follows:
(in millions) |  | 2020 |  | 2019 |  | 2018
Intrinsic value of performance share awards exercised |  | $ | 12.9 |  |  | $ | 5.0 |  |  | $ | 5.3 |
Fair value of performance share awards vested |  | $ | 11.3 |  |  | $ | 5.9 |  |  | $ | 5.2 |
Schedule of activity related to stock appreciation rights | A summary of stock appreciation awards outstanding and activity follows:
|  | Number of Shares (in thousands) |  | Weighted-Average Exercise Price (per share) |  | Weighted-Average Contractual Term (in years) |  | Aggregate Intrinsic Value (in millions)
Outstanding as of December 31, 2019 |  | 362 |  |  | $ | 106.85 |  |  |  |  |
Awards exercised |  | (3) |  |  | 106.85 |  |  |  |  |
Awards forfeited |  | (78) |  |  | 106.85 |  |  |  |  |
Outstanding as of December 31, 2020 |  | 281 |  |  | 106.85 |  |  | 0.3 |  | $ | 13.9 |
Stock appreciation rights |
Stock-based compensation |
Schedule of weighted-average assumptions for equity awards | The weighted average assumptions used in the December 31, 2020 determination of fair value for stock appreciation rights follows:
(in millions, except per share amounts) |  | 2018 One-time Grant
Expected dividend yield |  | 1.5 | %
Expected term (in years) |  | 0.3
Expected volatility |  | 30.1 | %
Risk-free interest rate |  | 0.1 | %
Weighted-average grant date fair value (per share) |  | $ | 48.24 |
Fair value of stock appreciation rights granted |  | $ | 13.5 |

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |